Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Doug Altman did nothing short of forever changing the fields of statistics and medical research. With that, he touched the lives of thousands, if not millions of people worldwide… a handful more than those who will miss him.

None

Yet, those who knew him personally will remember the down to earth research giant who always found the time to encourage, support, and inspire anyone and everyone who knocked on his door.

Doug's passion for and commitment to better research, one which impacts people's lives, inspired not only his own work, but also his colleagues, and multiple generations of scientists. His name equals transparency in research, dedication, commitment, and brilliance, all over the world.

Head of department Professor Andrew Carr says: "Doug Altman was an outstanding researcher who did an enormous amount over his career to improve the quality of medical research. His simple message was, if you are going to do research on patients then do it well and report it honestly. This approach has improved standards of care all over the world. He will be greatly missed by us all at NDORMS."

QuoteDoug_from_Sallie.jpg

Professor Sallie Lamb, Doug's successor as Director of the Centre for Statistics in Medicine adds: "Doug Altman. Fantastic scholar, leader and communicator, great colleague and friend to many from across the globe. Here at CSM we knew him as an inspirational, gentle, kind soul who genuinely enjoyed medical research and the company of medical researchers. We will cherish and honour his memory in the work we do."

Doug is one of the most influential medical statisticians of the past 40 years and worked relentlessly to improve the methodological quality of medical research. He was an advocate for transparency in scientific research and dedicated his career to developing essential tools for better design, analysis, clarity, and reporting of clinical and epidemiological research. Promoting the transparent and high quality reporting of evidence, Professor Altman has ultimately improved the care of patients.

He was Professor of Statistics in Medicine at the University of Oxford and authored numerous highly cited papers on statistical methodology. He founded and directed the Centre for Statistics in Medicine and Cancer Research UK Medical Statistics Group, and was co-founder of the international EQUATOR Network for health research reliability. He received the BMJ Lifetime Achievement Award in 2015.

Legends leave behind a big legacy and an enormous void. Today, we are all left so much poorer, with one less hero fighting our corner through meaningful research. May your legacy live long and prosper, if you cannot, Doug.

Our thoughts are with Doug's family at this very difficult time.

Doug's memory book

If you would like to contribute your memories and photos of happy times with Doug, please join his friends and colleagues at CSM.

Share your memories button

A part of Doug's legacy

CSM logo

EQUATOR Centre UK

 

Similar stories

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Study reveals the safety of bisphosphonates in chronic kidney disease

Main

The results of an observational study published in JMBR and funded by the Health Technology Assessment Programme shows that bisphosphonate use is associated with a greater risk of chronic kidney disease progression.

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.

Vascular loss shown to be the primary hallmark of aging

Kennedy Main Tissue remodelling and regeneration

New Research from the Kusumbe group at the Kennedy Institute of Rheumatology identifies vascular attrition, marked by pericyte to fibroblast differentiation, as a primary hallmark of aging and highlights organ-specific vascular changes with age.

Understanding the first wave of COVID-19 and implications for tackling the ongoing pandemic: evidence from 5.5 million people from Catalonia, Spain

Botnar Main Research Statistics and epidemiology

Health outcomes during the first wave of COVID-19 in Catalonia, Spain, have been described in detail in a study published by Nature Communications.